Mulmit

Nasus Pharma LtdNasus Pharma Ltd

NSRX NYSE

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-311,235,000,000-4,904,000-5,856,000-0.72

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-06-17Teleman Dan BenjaminChief Executive Officer6,550
2026-04-22Teleman Dan BenjaminChief Executive Officer2,900
2026-03-31Teleman Dan BenjaminChief Executive Officer15,000
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.